Skip to main content
NIH funding notice RFA-DA-19-005

Science-Based Quality Measurement and Management Development for Opioid Use Disorder Treatment (R61/R33 Clinical Trial Required)

Closed on November 7, 2018.

Posted
March 5, 2018
Close date
November 7, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,450,301 in first-year total cost, median $489,682.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 SXM-M (09)]3

Most frequent institutions

  1. BRANDEIS UNIVERSITY1
  2. NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
  3. PARTNERSHIP TO END ADDICTION1
Competing awards under RFA-DA-19-005 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Measuring Improvement in the Quality of ED-initiated Treatment for OUD using Observation1R61DA049265-01MCCORMACK, RYAN PNEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY$520,267ZDA1
2019Coaching Performance Driven Practice Change in the Context of Value Based Purchasing Under New York Medicaid1R61DA049252-01LINCOURT, PATRICIANEIGHBORS, CHARLES JPARTNERSHIP TO END ADDICTION, NY$489,682ZDA1
2019Piloting a Patient-Reported Outcome Measure for Opioid Use Disorder Recovery in a Clinical Setting1R61DA049263-01HORGAN, CONSTANCE M.REIF, SHARONBRANDEIS UNIVERSITY, MA$440,352ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.